يعرض 1 - 10 نتائج من 22 نتيجة بحث عن '"K. Kalinsky"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    دورية أكاديمية
    P018 TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) ± durvalumab vs investigator’s choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy

    المؤلفون: A. Bardia, L. Pusztai, K. Albain, K. Kalinsky, D. Hershman, W. Barlow, E. Tokunaga, E.M. Ciruelos, D. Loirat, C. Isaacs, L. Testa, H. Dry, R. Kozarski, M. Maxwell, N. Harbeck, P. Sharma

    المصدر: Breast, Vol 68, Iss , Pp S23- (2023)

    مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: http://www.sciencedirect.com/science/article/pii/S0960977623001376Test; https://doaj.org/toc/1532-3080Test

    الوصول الحر: https://doaj.org/article/172d62e86c204fd7992971f6eea33a55Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

    المؤلفون: J.R. Hecht, S.S. Raman, A. Chan, K. Kalinsky, J.-F. Baurain, M.M. Jimenez, M.M. Garcia, M.D. Berger, U.M. Lauer, A. Khattak, A. Carrato, Y. Zhang, K. Liu, E. Cha, A. Keegan, S. Bhatta, C.P. Strassburg, A. Roohullah

    المصدر: Hecht, J R; Raman, S S; Chan, A; Kalinsky, K; Baurain, J-F; Jimenez, M M; Garcia, M M; Berger, M D; Lauer, U M; Khattak, A; Carrato, A; Zhang, Y; Liu, K; Cha, E; Keegan, A; Bhatta, S; Strassburg, C P; Roohullah, A (2023). Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases. ESMO open, 8(2), p. 100884. BMJ 10.1016/j.esmoop.2023.100884 <http://dx.doi.org/10.1016/j.esmoop.2023.100884Test>
    ESMO open, vol 8, iss 2

    مصطلحات موضوعية: Adult, Cancer Research, Clinical Trials and Supportive Activities, Triple Negative Breast Neoplasms, 610 Medicine & health, drug therapy combination, Cohort Studies, gastrointestinal neoplasms, Clinical Research, Breast Cancer, breast neoplasms, Humans, Melanoma, Cancer, Oncolytic Virotherapy, viral immunotherapy, Liver Disease, Liver Neoplasms, Colo-Rectal Cancer, Good Health and Well Being, Oncology, Patient Safety, virotherapy, Colorectal Neoplasms, Digestive Diseases

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bceec2096f0cc01ea84f9fd89e2e34Test
    https://boris.unibe.ch/179470/1/1-s2.0-S2059702923001047-main.pdfTest


    أضف إلى المفضلة
  3. 3
    198P Relationship of diarrhea and neutropenia events with outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG): Post hoc analysis from the phase III ASCENT study

    المؤلفون: E. de Azambuja, F. Jacobs, M. Lambertini, H.S. Rugo, A. Bardia, S.M. Tolaney, J. O'Shaughnessy, R.J. Delaney, S. Zha, J. Liu, T. Valdez, K. Kalinsky, E. Agostinetto

    المصدر: ESMO Open. 8:101387

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d1e083b5ddd2a95286cce37a634c8649Test
    https://doi.org/10.1016/j.esmoop.2023.101387Test


    أضف إلى المفضلة
  4. 4
    Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol Z1K

    المؤلفون: K. Kalinsky, W. Zihan, C. McCourt, E.P. Mitchell, J.J. Wright, L.A. Doyle, R.J. Gray, V. Wang, L.M. McShane, L.V. Rubinstein, D. Patton, P.M. Williams, S.R. Hamilton, B.A. Conley, C.A. Arteaga, L.N. Harris, P.J. O’Dwyer, A.P. Chen, K.T. Flaherty

    المصدر: European Journal of Cancer. 174:S8-S9

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e34fc03d8fd82e7b02d428a8cb24cbd8Test
    https://doi.org/10.1016/s0959-8049Test(22)00824-3


    أضف إلى المفضلة
  5. 5
    273TiP ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens treated with ARX788

    المؤلفون: S.A. Hurvitz, K. Kalinsky, D. Tripathy, G. Sledge, W.J. Gradishar, J. O'Shaughnessy, S. Modi, H. Park, A. McCartney, S. Frentzas, C. Shannon, K. Cuff, R.W. Eek, M. Martin Jimenez, G. Curigliano, G. Jerusalem, C. Huang, M. Press, J. Lu

    المصدر: Annals of Oncology. 33:S662-S663

    مصطلحات موضوعية: Oncology, Hematology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::1ffabd9dbcc0cf0a0b9ea2e3e434d06dTest
    https://doi.org/10.1016/j.annonc.2022.07.1857Test


    أضف إلى المفضلة
  6. 6
    Radiotherapy Use and Locoregional Recurrence Rates on SWOG 1007, a US Cooperative Group Trial Enrolling Patients with Favorable-Risk Node-Positive Breast Cancer

    المؤلفون: R. Jagsi, W. Barlow, W.A. Woodward, E.P. Connolly, D. Shumway, C. Speers, S.R. Stecklein, H. Zhang, P. Sharma, L. Pusztai, G. Hortobagyi, K. Kalinsky

    المصدر: International Journal of Radiation Oncology*Biology*Physics. 114:S43

    مصطلحات موضوعية: Cancer Research, Radiation, Oncology, Radiology, Nuclear Medicine and imaging

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6c69f752c59f82b115472f851b94a2edTest
    https://doi.org/10.1016/j.ijrobp.2022.07.410Test


    أضف إلى المفضلة
  7. 7
    168P Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study

    المؤلفون: S.A. Hurvitz, A. Bardia, K. Punie, K. Kalinsky, J. Cortés, J. O'Shaughnessy, L.A. Carey, H.S. Rugo, O.K. Yoon, Y. Pan, R.J. Delaney, S. Hofsess, P. Hodgkins, S-C. Phan, V. Dieras

    المصدر: Annals of Oncology. 33:S200-S201

    مصطلحات موضوعية: Oncology, Hematology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::12092508458654ef428e55da97bcef69Test
    https://doi.org/10.1016/j.annonc.2022.03.187Test


    أضف إلى المفضلة
  8. 8
    274TiP Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01

    المؤلفون: A. Bardia, K. Kalinsky, J. Tsurutani, E.P. Hamilton, S. Johnston, J. Sohn, K.H. Park, Y.H. Park, S-A. Im, K.S. Lee, D. Dastur, V. Haddad, S. Khan, B. Xu, B. Pistilli, H.S. Rugo

    المصدر: Annals of Oncology. 33:S663

    مصطلحات موضوعية: Oncology, Hematology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::76b1c74f6860635d5df8eb5180511dfbTest
    https://doi.org/10.1016/j.annonc.2022.07.1858Test


    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    Safety, Feasibility, and Biomarker Effects of High-Dose Vitamin D Supplementation Among Women at High Risk for Breast Cancer

    المؤلفون: KD, Crew, T, Xiao, PS, Thomas, MB, Terry, M, Maurer, K, Kalinsky, S, Feldman, L, Brafman, SR, Refice SR, DL, Hershman

    المصدر: International Journal of Food Science, Nutrition and Dietetics ; page 1-9 ; ISSN 2326-3350

    الإتاحة: https://doi.org/10.19070/2326-3350-si01001Test

    View record in BASE

    أضف إلى المفضلة
  10. 10
    Erratum to 'Gene expression signatures for tailoring adjuvant chemotherapy of luminal breast cancer: stronger evidence, greater trust'

    المؤلفون: M.J. Piccart, K. Kalinsky, R. Gray, W.E. Barlow, C. Poncet, F. Cardoso, E. Winer, J. Sparano

    المصدر: Annals of Oncology. 33:668

    مصطلحات موضوعية: Oncology, Hematology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::3b34f7cf107eb114414573e4bef6b7a1Test
    https://doi.org/10.1016/j.annonc.2022.04.001Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث